PFF Webinar Library

fda-stamp-of-approval-and-medications

The FDA's Drug Approval Process

Fri, Sep 28, 2018

Learn about FDA requirements for drug approval, frequently used FDA terminology, and therapies for IPF.

Dr. Banu Karimi-Shah of the FDA - Center for Drug Evaluation and Research, Division of Pulmonary, Allergy, and Rheumatology Products joins us to give background information on the FDA requirements for drug approval, frequently used FDA terminology, and therapies for IPF.

Recent Webinars

  • Aug
    28
    2024

    EXPOSED: The Impact of Inhaled Exposures on PF

    View Webinar
  • pulmonary-fibrosis-lungs
    Jul
    24
    2024

    Lung Transplant: How to prepare

    View Webinar
  • Jun
    26
    2024

    Medications for PF

    View Webinar
  • May
    29
    2024

    Pulmonary Fibrosis and Pulmonary Rehabilitation: Exercise, Education, and Empowerment

    View Webinar